Topotecan versus paclitaxel in second-line therapy: A lost opportunity for quality-of-life evaluation? (multiple letter) [1]

G. Apolone, A. Buda, Graham A. Ross, J. A. Kettels

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)1443-1444
Number of pages2
JournalAnnals of Oncology
Volume15
Issue number9
DOIs
Publication statusPublished - Sep 2004

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Topotecan versus paclitaxel in second-line therapy : A lost opportunity for quality-of-life evaluation? (multiple letter) [1]. / Apolone, G.; Buda, A.; Ross, Graham A.; Kettels, J. A.

In: Annals of Oncology, Vol. 15, No. 9, 09.2004, p. 1443-1444.

Research output: Contribution to journalArticle

@article{401c0c5d12fa4de2ae12211abebf1daf,
title = "Topotecan versus paclitaxel in second-line therapy: A lost opportunity for quality-of-life evaluation? (multiple letter) [1]",
author = "G. Apolone and A. Buda and Ross, {Graham A.} and Kettels, {J. A.}",
year = "2004",
month = "9",
doi = "10.1093/annonc/mdh357",
language = "English",
volume = "15",
pages = "1443--1444",
journal = "Annals of Oncology",
issn = "0923-7534",
publisher = "NLM (Medline)",
number = "9",

}

TY - JOUR

T1 - Topotecan versus paclitaxel in second-line therapy

T2 - A lost opportunity for quality-of-life evaluation? (multiple letter) [1]

AU - Apolone, G.

AU - Buda, A.

AU - Ross, Graham A.

AU - Kettels, J. A.

PY - 2004/9

Y1 - 2004/9

UR - http://www.scopus.com/inward/record.url?scp=4644364705&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4644364705&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdh357

DO - 10.1093/annonc/mdh357

M3 - Article

C2 - 15319253

AN - SCOPUS:4644364705

VL - 15

SP - 1443

EP - 1444

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 9

ER -